Table 1.
Marker | Overall | eGFRCr-Cys <60 | eGFRCr-Cys 60–89 | eGFRCr-Cys 90–134 | eGFRCr-Cys ≥135 | |||||
---|---|---|---|---|---|---|---|---|---|---|
r | P Value | r | P Value | r | P Value | r | P Value | r | P Value | |
Total Study Populationc | ||||||||||
Fasting glucose | −0.17 | <0.001 | −0.35 | <0.001 | −0.17 | <0.001 | −0.16 | <0.001 | −0.68 | <0.001 |
HbA1c | −0.25 | <0.001 | −0.53 | <0.001 | −0.25 | <0.001 | −0.24 | <0.001 | −0.66 | <0.001 |
Fructosamine | −0.28 | <0.001 | −0.47 | <0.001 | −0.27 | <0.001 | −0.27 | <0.001 | −0.70 | <0.001 |
Glycated albumin | −0.29 | <0.001 | −0.41 | <0.001 | −0.27 | <0.001 | −0.28 | <0.001 | −0.70 | <0.001 |
eGFRCr-Cys | −0.11 | <0.001 | 0.25 | <0.001 | −0.001 | 0.5 | −0.12 | <0.001 | −0.25 | 0.05 |
eGFRβ2M | −0.11 | <0.001 | 0.16 | 0.002 | −0.06 | <0.001 | −0.12 | <0.001 | −0.15 | 0.2 |
Participants Without Diagnosed Diabetesd | ||||||||||
Fasting glucose | −0.02 | 0.03 | −0.08 | 0.2 | −0.03 | 0.06 | −0.02 | 0.1 | −0.28 | 0.06 |
HbA1c | −0.09 | <0.001 | −0.14 | 0.02 | −0.09 | <0.001 | −0.09 | <0.001 | −0.35 | 0.02 |
Fructosamine | −0.13 | <0.001 | −0.11 | 0.07 | −0.13 | <0.001 | −0.14 | <0.001 | −0.30 | 0.04 |
Glycated albumin | −0.14 | <0.001 | −0.02 | 0.7 | −0.12 | <0.001 | −0.15 | <0.001 | −0.29 | 0.05 |
eGFRCr-Cys | −0.12 | <0.001 | 0.13 | 0.03 | −0.03 | 0.05 | −0.11 | <0.001 | −0.21 | 0.2 |
eGFRβ2M | −0.14 | <0.001 | −0.002 | 0.9 | −0.10 | <0.001 | −0.13 | <0.001 | −0.24 | 0.1 |
Participants With Diagnosed Diabetese | ||||||||||
Fasting glucose | −0.77 | <0.001 | −0.60 | <0.001 | −0.76 | <0.001 | −0.79 | <0.001 | −0.28 | 0.3 |
HbA1c | −0.84 | <0.001 | −0.76 | <0.001 | −0.83 | <0.001 | −0.86 | <0.001 | −0.58 | 0.01 |
Fructosamine | −0.83 | <0.001 | −0.65 | <0.001 | −0.81 | <0.001 | −0.85 | <0.001 | −0.32 | 0.2 |
Glycated albumin | −0.83 | <0.001 | −0.62 | <0.001 | −0.81 | <0.001 | −0.86 | <0.001 | −0.28 | 0.2 |
eGFRCr-Cys | −0.19 | <0.001 | 0.07 | 0.4 | −0.02 | 0.8 | −0.17 | <0.001 | −0.24 | 0.3 |
eGFRβ2M | −0.17 | <0.001 | 0.17 | 0.07 | −0.002 | 0.9 | −0.14 | <0.001 | −0.008 | 0.9 |
Abbreviations: eGFRβ2M, estimated glomerular filtration rate based on β2-microglobulin; eGFRCr-Cys, estimated glomerular filtration rate based on creatinine and cystatin C; HbA1c, glycated hemoglobin.
a Spearman's rank correlation coefficients and P values.
b eGFRCr-Cys in units of mL/min/1.73 m2; 87 participants were missing data for cystatin C.
c The overall number of subjects was 13,277; for the categories of eGFRCr-Cys <60, 60–89, 90–134, and ≥135, the numbers of participants were 370, 4,207, 8,547, and 66, respectively.
d The overall number of subjects without diagnosed diabetes was 12,033; for the categories of eGFRCr-Cys <60, 60–89, 90–134, and ≥135, the numbers of participants were 260, 3,828, 7,825, and 47, respectively.
e The overall number of subjects with diagnosed diabetes was 1,244; for the categories of eGFRCr-Cys <60, 60–89, 90–134, and ≥135, the numbers of participants were 110, 379, 722, and 19, respectively.